Williams Patrick F. 4

4 · STAAR SURGICAL CO · Filed Mar 11, 2025

Form 4

Period: 2025-03-07

Chief Financial Officer

Transactions

Exercise/Conversion
Performance Stock Units
2025-03-07−2,614→ 0 total
Exercise: $0.00→ Common Stock (2,614 underlying)
Exercise/Conversion
Common Stock
2025-03-07+2,614→ 40,953 total
Exercise/Conversion
Common Stock
2025-03-07+3,075→ 44,028 total
Exercise/Conversion
Restricted Stock Units
2025-03-10−4,061→ 4,062 total
Exercise: $0.00→ Common Stock (4,061 underlying)
Exercise/Conversion
Common Stock
2025-03-10+4,061→ 48,089 total
Exercise/Conversion
Restricted Stock Units
2025-03-07−3,075→ 0 total
Exercise: $0.00→ Common Stock (3,075 underlying)

Footnotes (5)

[F1]Reflects performance stock units (PSUs) granted to the Reporting Person on March 7, 2022, based on the Corporation's performance relative to pre-established financial metrics. These PSUs vested as to 1/3 (2,614 shares) on March 7, 2023, 1/3 (2,614 shares) on March 7, 2024, and 1/3 (2,614 shares) on March 7, 2025.
[F2]Reflects restricted stock units (RSUs) granted to the Reporting Person on March 7, 2022. These RSUs vested as to 1/3 (3,075 shares) on March 7, 2023, 1/3 (3,075 shares) on March 7, 2024, and 1/3 (3,075 shares) on March 7, 2025.
[F3]Reflects RSUs granted to the Reporting Person on March 10, 2023. These RSUs vested as to 1/3 (4,061 shares) on March 10, 2024, 1/3 (4,061 shares) on March 10, 2025, and will vest as to the remaining 1/3 (4,062 shares) on March 10, 2026.
[F4]Includes previously granted RSUs, which are subject to future vesting.
[F5]Each PSU and RSU represents the right to receive one share of the Corporation's common stock upon vesting.

Documents

1 file